These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9072885

  • 1. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
    Svára F, Sulková S, Kvasnićka J, Polakovic V.
    Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B.
    Ren Fail; 2005 Dec; 27(4):367-72. PubMed ID: 16060121
    [Abstract] [Full Text] [Related]

  • 5. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Dec; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 6. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B.
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M, Mehls O, Schaefer F.
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [Abstract] [Full Text] [Related]

  • 19. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N.
    Adv Perit Dial; 2000 Oct; 16():80-4. PubMed ID: 11045266
    [Abstract] [Full Text] [Related]

  • 20. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A, Spasovski G, Zafirov D, Polenakovic M.
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.